Modeling Intratumor Heterogeneity in Breast Cancer

Advances in 3D bioprinting have allowed the creation of more complex models with improved physiologic representation while controlling for reproducibility and accuracy. The authors discuss the advantages and challenges of current 3D in vitro models for evaluating therapy response in breast cancer.